What We're Reading: Page 288
Industry reads hand-picked by our editors
Sep 13, 2017
Sep 12, 2017
-
The New York Times
Suicide data incorrectly reported in drug trials, suit claimed
-
Scientific American
Powerful childhood cancer treatment holds promise — and poses hazards
-
The Guardian
Pharmaceutical companies gave $12m to doctors, nurses and pharmacists
Sep 11, 2017
-
TechCrunch
23andMe’s second act sits squarely in drug research and development
-
The Washington Post
Tick saliva may be a secret ingredient to help HIV patients
-
Financial Times
Magic mushrooms take a trip into clinical trials
-
Business Insider
A biotech CEO who sold his last company for $14 billion explains why he wants to do things differently this time
Sep 08, 2017
Sep 07, 2017
Sep 06, 2017
-
Financial Times
Secretive Moderna yet to convince on $5bn valuation
-
Forbes
New blood needed: Pharma R&D leadership tenure
-
The Wall Street Journal
Don’t ignore big pharma’s new breakthrough
Sep 05, 2017
-
The Wall Street Journal
Takeda Pharmaceutical Prescribes Stability After Rough Start
-
The New York Times
Opioids Aren’t the Only Pain Drugs to Fear
-
Reuters
Medical device maker Teleflex to buy NeoTract in $1.1 billion deal
Previous
